BIOTIME, INC DEF 14A 11-4-2014

Company

Lineage Cell Therapeutics, Inc.

Filed

October 14, 2014

Period of Report

November 4, 2014

Accession Number

0001140361-14-037970

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →